These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29385658)

  • 21. The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson's therapeutics.
    Rubilar JC; Outeiro TF; Klein AD
    Brain; 2024 Aug; 147(8):2610-2620. PubMed ID: 38437875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease.
    Papadopoulos VE; Nikolopoulou G; Antoniadou I; Karachaliou A; Arianoglou G; Emmanouilidou E; Sardi SP; Stefanis L; Vekrellis K
    Hum Mol Genet; 2018 May; 27(10):1696-1710. PubMed ID: 29547959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.
    Kim MJ; Jeon S; Burbulla LF; Krainc D
    Hum Mol Genet; 2018 Jun; 27(11):1972-1988. PubMed ID: 29579237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.
    Pang SY; Lo RCN; Ho PW; Liu HF; Chang EES; Leung CT; Malki Y; Choi ZY; Wong WY; Kung MH; Ramsden DB; Ho SL
    Transl Neurodegener; 2022 Jan; 11(1):5. PubMed ID: 35101134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines.
    Smith LJ; Bolsinger MM; Chau KY; Gegg ME; Schapira AHV
    Hum Mol Genet; 2023 Feb; 32(5):773-789. PubMed ID: 36130205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuroinflammatory role of glucocerebrosidase in Parkinson's disease.
    Bo RX; Li YY; Zhou TT; Chen NH; Yuan YH
    Neuropharmacology; 2022 Apr; 207():108964. PubMed ID: 35065083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy.
    Kuo SH; Tasset I; Cheng MM; Diaz A; Pan MK; Lieberman OJ; Hutten SJ; Alcalay RN; Kim S; Ximénez-Embún P; Fan L; Kim D; Ko HS; Yacoubian T; Kanter E; Liu L; Tang G; Muñoz J; Sardi SP; Li A; Gan L; Cuervo AM; Sulzer D
    Sci Adv; 2022 Feb; 8(6):eabm6393. PubMed ID: 35138901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.
    Ruz C; Barrero FJ; Pelegrina J; Bandrés-Ciga S; Vives F; Duran R
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles.
    Jewett KA; Thomas RE; Phan CQ; Lin B; Milstein G; Yu S; Bettcher LF; Neto FC; Djukovic D; Raftery D; Pallanck LJ; Davis MY
    PLoS Genet; 2021 Feb; 17(2):e1008859. PubMed ID: 33539341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.
    Balestrino R; Schapira AHV
    Neuroscientist; 2018 Oct; 24(5):540-559. PubMed ID: 29400127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells.
    Deen MC; Zhu Y; Gros C; Na N; Gilormini PA; Shen DL; Bhosale S; Anastasi N; Wang R; Shan X; Harde E; Jagasia R; Lynn FC; Vocadlo DJ
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2200553119. PubMed ID: 35858317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration.
    Polissidis A; Koronaiou E; Nikolopoulou G; Viel C; Nikatou M; Bogiongko M; Sardi SP; Xilouri M; Vekrellis K; Stefanis L
    Neurobiol Dis; 2022 Feb; 163():105612. PubMed ID: 34995756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson's disease.
    Muñoz SS; Petersen D; Marlet FR; Kücükköse E; Galvagnion C
    Biophys Chem; 2021 Jun; 273():106534. PubMed ID: 33832803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease.
    Ron I; Rapaport D; Horowitz M
    Hum Mol Genet; 2010 Oct; 19(19):3771-81. PubMed ID: 20643691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.
    Beavan MS; Schapira AH
    Ann Med; 2013 Dec; 45(8):511-21. PubMed ID: 24219755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult.
    Henderson MX; Sedor S; McGeary I; Cornblath EJ; Peng C; Riddle DM; Li HL; Zhang B; Brown HJ; Olufemi MF; Bassett DS; Trojanowski JQ; Lee VMY
    Neuron; 2020 Mar; 105(5):822-836.e7. PubMed ID: 31899072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
    Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
    Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease.
    Kurzawa-Akanbi M; Hanson PS; Blain PG; Lett DJ; McKeith IG; Chinnery PF; Morris CM
    J Neurochem; 2012 Oct; 123(2):298-309. PubMed ID: 22803570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.